BenResearch_OR said:— in my experience this comes down to a few key factors
Gonna push back on this one. Lp(a) on GLP-1 agonists any impact is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.
Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.
Adding my data to this Lp(a) on GLP-1 agonists discussion:
| Metric | Baseline | Month 5 | Month 6 |
|---|---|---|---|
| Weight | 268 lbs | 243 lbs | 203 lbs |
| A1C | 7.2% | 6.0% | 5.2% |
| hsCRP | 7.0 | 4.0 | 1.0 |
Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.5g/kg/day.
Dr.NateNeph — wow. This community is amazing.
Slightly tangential to Lp(a) on GLP-1 agonists but claudia_zurich reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.